Tralokinumab [1044515-88-9]

TargetMol Chemicals

Tralokinumab

9

Antibody

Research Use Only

Tralokinumab

SDS-PAGE:95% SEC-HPLC:99.99%

Tralokinumab is a fully human IgG4 monoclonal antibody with a high affinity for IL-13 alone. Tralokinumabs potential anti-inflammatory activity prevents IL-13 receptor interaction and subsequent downstream signaling and can be used to study atopic dermatitis (AD).

3 years

-20°C

12352203